CAPTAIN: Effects of age on response to triple therapy in patients with inadequately controlled asthma on ICS/LABA

被引：0

作者：

Boulet, Louis-Philippe ^{[1
]}

Lee, Laurie ^{[2
]}

Kerstjens, Huib ^{[3
,4
]}

Papi, Alberto ^{[5
]}

Zarankaite, Agne ^{[6
]}

Pavord, Ian D. ^{[7
]}

Bailes, Zelie ^{[6
]}

Brusselle, Guy ^{[8
]}

Barnes, Neil ^{[9
,10
]}

Hanania, Nicola A. ^{[11
]}

Pascoe, Steven ^{[2
]}

Oppenheimer, John ^{[12
]}

Pizzichini, Emilio ^{[13
,14
,15
,16
]}

Fowler, Andrew ^{[6
]}

机构：

[1] Laval Univ, Quebec City, PQ, Canada

[2] GlaxoSmithKline, Collegeville, PA USA

[3] Univ Groningen, Groningen, Netherlands

[4] Univ Med Ctr Groningen, Groningen, Netherlands

[5] Univ Ferrara, Ferrara, Italy

[6] GlaxoSmithKline, Stockley Pk West, Uxbridge, Middx, England

[7] Univ Oxford, Oxford, England

[8] Ghent Univ Hosp, Ghent, Belgium

[9] GlaxoSmithKline, London, England

[10] London Sch Med & Dent, London, England

[11] Baylor Coll Med, Houston, TX 77030 USA

[12] Rutgers New Jersey Med Sch, Newark, NJ USA

[13] GlaxoSmithKline, Brentford, Middx, England

[14] Univ Fed Santa Catarina, Brentford, Middx, England

[15] GlaxoSmithKline, Florianopolis, SC, Brazil

[16] Univ Fed Santa Catarina, Florianopolis, SC, Brazil

来源：

EUROPEAN RESPIRATORY JOURNAL | 2020年 / 56卷

关键词：

Elderly; Treatments; Asthma;

D O I：

10.1183/13993003.congress-2020.2631

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

2631

引用

页数：3

共 50 条

[41] Extrafine triple therapy delays COPD clinically important deterioration vs ICS/LABA, LAMA, or LABA/LAMA
Singh, Dave
Fabbri, Leonardo M.
Vezzoli, Stefano
Petruzzelli, Stefano
Papi, Alberto
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2019, 14 : 531 - 546
[42] Safety profile of triple ICS/LABA/LAMA FDC in the treatment of asthma: a meta-analysis
Calzetta, L.
Cavalli, F.
Chetta, A.
Cazzola, M.
Rogliani, P.
EUROPEAN RESPIRATORY JOURNAL, 2022, 60
[43] Adding a LAMA to ICS/LABA Therapy A Meta-analysis of Triple Combination Therapy in COPD
Calzetta, Luigino
Cazzola, Mario
Matera, Maria Gabriella
Rogliani, Paola
CHEST, 2019, 155 (04) : 758 - 770
[44] Impact of inadequately controlled asthma: a need for targeted therapy?
Mehlhop, PD
Blake, K
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2004, 29 (03) : 189 - 194
[45] Cost-effectiveness of a single inhaler triple therapy versus ICS/LABA in COPD
Martin, Alan A.
Shah, Dhvani
Goodall, Emma C.
Schroeder, Melanie
Risebrough, Nancy
Ndirangu, Kerigo
Ismaila, Afisi S.
EUROPEAN RESPIRATORY JOURNAL, 2018, 52
[46] THE DOSE OF ICS IN TRIPLE ICS/LABA/LAMA FDC MODULATES INFLAMMATION IN A HUMAN EX VIVO MODEL OF SEVERE EOSINOPHILIC ASTHMA
Rogliani, Paola
Ora, Josuel
Motta, Enrico
Laitano, Rossella
Calzetta, Luigino
CHEST, 2023, 164 (04) : 4918A - 4918A
[47] THE BURDEN OF ICS/LABA-TREATED ASTHMA PATIENTS IN THE UK ADULT POPULATION
Price, D.
Mathieson, N.
Mulgirigama, A.
Scowcroft, A.
Pedersini, R.
Isherwood, G.
Pavord, I. D.
THORAX, 2013, 68 : A82 - A82
[48] Disease control and treatment pathways of asthma patients after initiating ICS/LABA
Buhl, Roland
Heaney, Liam G.
Loefroth, Emil
Larbig, Paul Michael
Kostikas, Konstantinos
Conti, Valentino
Cao, Hui
EUROPEAN RESPIRATORY JOURNAL, 2018, 52
[49] Use of ICS/LABA on Asthma Exacerbation Risk in Patients Within a Medical Group
Stanford, Richard H.
Nagar, Saurabh
Lin, Xiwu
O'Connor, Richard D.
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2015, 21 (11): : 1014 - 1019
[50] Potential Drawbacks of ICS/LABA/LAMA Triple Fixed-Dose Combination Therapy in the Treatment of Asthma: A Quantitative Synthesis of Safety Profile
Rogliani, Paola
Cavalli, Francesco
Chetta, Alfredo
Cazzola, Mario
Calzetta, Luigino
JOURNAL OF ASTHMA AND ALLERGY, 2022, 15 : 565 - 577

← 1 2 3 4 5 →